Basit öğe kaydını göster

An open-label, multicenter, efficacy and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results

dc.contributor.authorKarakaş, Zeynep
dc.date.accessioned2022-07-04T12:18:36Z
dc.date.available2022-07-04T12:18:36Z
dc.identifier.citationKarakaş Z., "An open-label, multicenter, efficacy and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results", AMERICAN JOURNAL OF HEMATOLOGY, ss.1234-12243, 2022
dc.identifier.issn0361-8609
dc.identifier.othervv_1032021
dc.identifier.otherav_16720849-7f67-4ea2-9dbf-d54fc63d4582
dc.identifier.urihttp://hdl.handle.net/20.500.12627/181728
dc.identifier.urihttps://doi.org/10.1002/ajh.26592
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.titleAn open-label, multicenter, efficacy and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results
dc.typeMakale
dc.relation.journalAMERICAN JOURNAL OF HEMATOLOGY
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.startpage1234
dc.identifier.endpage12243
dc.contributor.firstauthorID3422035


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster